Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic | mijn-bsl Skip to main content

Mijn bibliotheek

Shop

Nieuws
Boeken
Tijdschriften
E-learning
Web-tv
Video
Audio

Tips voor Mijn BSL

UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 1/2022

22-06-2021

Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic

Auteurs: Kyriakos Souliotis, Theodoros V. Giannouchos, Chistina Golna, Evangelos Liberopoulos

Gepubliceerd in: Quality of Life Research | Uitgave 1/2022

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

We estimate the association between forgetfulness to take medications as prescribed and polypharmacy and health-related quality of life (HRQoL) among a cohort of patients with hypertension, dyslipidemia or both in Greece during the COVID-19 pandemic.

Methods

A telephone survey of 1018 randomly selected adults was conducted in Greece in June 2020. Participants were included in the survey, if they (a) had a diagnosis of hypertension, dyslipidemia or both and (b) were on prescription treatment for these conditions. HRQoL was calculated using the short form (SF) -12 Patient Questionnaire. A multivariable generalized linear regression model (GLM) was used to estimate the association between forgetfulness and polypharmacy and HRQoL, controlling for sociodemographic and health-related covariates.

Results

Overall, 351 respondents met the inclusion criteria, of whom 28 did not fully complete the questionnaire (response rate: 92%, n = 323). Of those, 37% were diagnosed with hypertension only, 28% with dyslipidemia only, and 35% with both. Most reported good to average physical (64.1%) and mental health (48.6%). Overall, 25% indicated that they sometimes forget to take their prescribed medications, and 12% took two or more pills multiple times daily. Total HRQoL score was 68.9% (s.d. = 18.0%). About 10% of participants reported paying less attention to their healthcare condition during the pandemic. Estimates of multivariable analyses indicated a negative association between forgetfulness (− 9%, adjusted β: − 0.047, 95% confidence interval − 0.089 to − 0.005, p = 0.029), taking two or more pills multiple times daily compared to one pill once a day (− 16%, adjusted β: − 0.068, 95% confidence interval − 0.129 to − 0.008, p = 0.028) and total HRQoL.

Conclusion

Our results suggest that among adult patients with hypertension, dyslipidemia or both in Greece, those who forget to take their medications and those with more complex treatment regimens had lower HRQoL. Such patients merit special attention and require targeted approaches by healthcare providers to improve treatment compliance and health outcomes.
vorige artikel Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysis
volgende artikel Measurement invariance of the short Warwick-Edinburgh Mental Wellbeing Scale and latent mean differences (SWEMWBS) in young people by current care status
Literatuur
1.
Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 5, 1–5.
2.
Venkitachalam, L., Wang, K., Porath, A., Corbalan, R., Hirsch, A. T., Cohen, D. J., Smith, S. C., Jr., Ohman, E. M., Steg, P. G., Bhatt, D. L., Magnuson, E. A., & REACH Registry Investigators. (2012). Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance. Circulation, 125(15), 1858–1869. PubMed
3.
4.
Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M. J., Paciorek, C. J., Singh, G., Hajifathalian, K., Bennett, J. E., & Taddei, C. (2017). Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19· 1 million participants. The Lancet, 389(10064), 37–55.
5.
Taddei, C., Zhou, B., Bixby, H., & NCD Risk Factor Collaboration (NCD-RisC). (2020). Repositioning of the global epicentre of non-optimal cholesterol. Nature, 4(582), 73–77.
6.
Panagiotakos, D. B., Georgousopoulou, E. N., Pitsavos, C., Chrysohoou, C., Metaxa, V., Georgiopoulos, G. A., Kalogeropoulou, K., Tousoulis, D., Stefanadis, C., & ATTICA Study group. (2015). Ten-year (2002–2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: The ATTICA study. International Journal of Cardiology, 180, 178–84. PubMed
7.
Jia, H., Zack, M. M., & Thompson, W. W. (2013). The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy. Value in Health, 16(1), 140–147. PubMed
8.
Trevisol, D. J., Moreira, L. B., Kerkhoff, A., Fuchs, S. C., & Fuchs, F. D. (2011). Health-related quality of life and hypertension: A systematic review and meta-analysis of observational studies. Journal of Hypertension, 29(2), 179–188. PubMed
9.
10.
11.
Sullivan, P. W., Ghushchyan, V., Wyatt, H. R., Wu, E. Q., & Hill, J. O. (2007). Productivity costs associated with cardiometabolic risk factor clusters in the United States. Value in Health, 10(6), 443–450. PubMed
12.
Sofi, F., Cesari, F., Abbate, R., Gensini, G. F., & Casini, A. (2008). Adherence to Mediterranean diet and health status: Meta-analysis. BMJ, 337, a1344. PubMedPubMedCentral
13.
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., & Lamuela-Raventos, R. M. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine, 368(14), 1279–1290.
14.
Alexopoulos, D., Anastasiou-Nana, M., Elisaf, M. S., Liberopoulos, E., Rallidis, L. S., Davos, C. H., Moulis, A., Nikas, N., Zacharis, E., Vardas, P., & CHALLENGE Investigators. (2016). A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients’ quality of life in Greece: The CHALLENGE study. International Journal of Cardiology, 217, 183–189. PubMed
15.
Liberopoulos, E., Vlasserou, F., Mitrogianni, Z., Papageorgantas, I., & Elisaf, M. (2012). Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece. Angiology, 63(3), 184–193. PubMed
16.
Liberopoulos, E. N., Florentin, M., Mikhailidis, D. P., & Elisaf, M. S. (2008). Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opinion on Drug Safety, 7(6), 717–725. PubMed
17.
Lalonde, L., Blais, L., Bérard, A., & Perreault, S. (2010). Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value in Health, 13(1), 87–94. PubMed
18.
Schoenthaler, A., Rosenthal, D. M., Butler, M., & Jacobowitz, L. (2018). Medication adherence improvement similar for shared decision-making preference or longer patient-provider relationship. Journal of the American Board of Family Medicine, 31(5), 752–760. PubMed
19.
Morrison, V. L., Holmes, E. A., Parveen, S., Plumpton, C. O., Clyne, W., De Geest, S., Dobbels, F., Vrijens, B., Kardas, P., & Hughes, D. A. (2015). Predictors of self-reported adherence to antihypertensive medicines: A multinational, cross-sectional survey. Value in Health, 18(2), 206–216. PubMed
20.
Tsiantou, V., Pantzou, P., Pavi, E., Koulierakis, G., & Kyriopoulos, J. (2010). Factors affecting adherence to antihypertensive medication in Greece: Results from a qualitative study. Patient Preference and Adherence, 4, 335. PubMedPubMedCentral
21.
Ho, P. M., Magid, D. J., Shetterly, S. M., Olson, K. L., Maddox, T. M., Peterson, P. N., Masoudi, F. A., & Rumsfeld, J. S. (2008). Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. American Heart Journal, 155(4), 772–779. PubMed
22.
Conn, V. S., Ruppar, T. M., & Cooper, P. S. (2016). Patient-centered outcomes of medication adherence interventions: Systematic review and meta-analysis. Value in Health, 19(2), 277–285. PubMedPubMedCentral
23.
24.
Bonaventura, M., Copher, R., Basurto, E., Faria, C., & Lorenzo, R. (2014). The association between non-adherence and quality of life among women with metastatic breast cancer. Value in Health, 17(3), A92.
25.
Patrick, A. R., Shrank, W. H., Glynn, R. J., Solomon, D. H., Dormuth, C. R., Avorn, J., Cadarette, S. M., Mogun, H., & Brookhart, M. A. (2011). The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value in Health, 14(4), 513–20. PubMedPubMedCentral
26.
Jneid, S., Jabbour, H., Hajj, A., Sarkis, A., Licha, H., Hallit, S., & Khabbaz, L. R. (2018). Quality of life and its association with treatment satisfaction, adherence to medication, and trust in physician among patients with hypertension: A cross-sectional designed study. Journal of Cardiovascular Pharmacology and Therapeutics, 23(6), 532–542. PubMed
27.
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 1, 521–530.
28.
Silavanich, V., Nathisuwan, S., Phrommintikul, A., & Permsuwan, U. (2019). Relationship of medication adherence and quality of life among heart failure patients. Heart and Lung, 48(2), 105–110. PubMed
29.
Zioga, E., Kazakos, K., Dimopoulos, E., Koutras, C., Marmara, K., Marmara, E. E., Marmaras, A., & Lavdaniti, M. (2016). Adherence and quality of life in patients with type II diabetes mellitus in northern Greece. Materia Socio-Medica, 28(4), 258. PubMedPubMedCentral
30.
Schenker, Y., Park, S. Y., Jeong, K., Pruskowski, J., Kavalieratos, D., Resick, J., Abernethy, A., & Kutner, J. S. (2019). Associations between polypharmacy, symptom burden, and quality of life in patients with advanced, life-limiting illness. Journal of General Internal Medicine, 34(4), 559–66. PubMedPubMedCentral
31.
Vyas, A., Kang, F., & Barbour, M. (2020). Association between polypharmacy and health-related quality of life among US adults with cardiometabolic risk factors. Quality of Life Research, 29(4), 977–986. PubMed
32.
Vyas, A., Alghaith, G., & Hufstader-Gabriel, M. (2020). Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: A population-level analysis. Quality of Life Research, 29(8), 2029–2037. PubMed
33.
Martínez, Y. V., Prado-Aguilar, C. A., Rascón-Pacheco, R. A., & Valdivia-Martínez, J. J. (2008). Quality of life associated with treatment adherence in patients with type 2 diabetes: A cross-sectional study. BMC Health Services Research, 8(1), 164. PubMedPubMedCentral
34.
Yfantopoulos, J. N., & Chantzaras, A. (2018). Drug policy in Greece. Value Health Regional Issues, 1(16), 66–73.
35.
36.
Anderson, K. E., McGinty, E. E., Presskreischer, R., & Barry, C. L. (2021). Reports of forgone medical care among US adults during the initial phase of the COVID-19 pandemic. JAMA Network Open, 4(1), e2034882. PubMedPubMedCentral
37.
Pineda-Sic, R. A., Galarza-Delgado, D. A., Serna-Peña, G., Castillo-Torres, S. A., Flores-Alvarado, D. E., Esquivel-Valerio, J. A., & Hernández-Galarza, I. D. (2021). Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience. Annals of the Rheumatic Diseases, 80(6), e85.
38.
Fragoulis, G. E., Evangelatos, G., Arida, A., Bournia, V. K., Fragiadaki, K., Karamanakos, A., Kravvariti, E., Laskari, K., Panopoulos, S., Pappa, M., & Tektonidou, M. G. (2021). Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic. Annals of the Rheumatic Diseases, 80(4), e60.
39.
Kaye, L., Theye, B., Smeenk, I., Gondalia, R., Barrett, M. A., & Stempel, D. A. (2020). Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. The Journal of Allergy and Clinical Immunology: In Practice, 8(7), 2384–2385. PubMed
40.
Betcherman, G., Giannakopoulos, N., Laliotis, I., Pantelaiou, I., Testaverde, M., & Tzimas, G. (2020). Reacting quickly and protecting jobs: The short-term impacts of the COVID-19 lockdown on the Greek labor market. Washington: World Bank.
41.
Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., Bullinger, M., Kaasa, S., Leplege, A., Prieto, L., & Sullivan, M. (1998). Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: Results from the IQOLA project. Journal of Clinical Epidemiology, 51, 1171–8. PubMed
42.
Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 1, 851–859.
43.
Kontodimopoulos, N., Pappa, E., Niakas, D., & Tountas, Y. (2007). Validity of SF-12 summary scores in a Greek general population. Health and Quality of Life Outcomes, 5(1), 1–9.
44.
Nguyen, T. M., Caze, A. L., & Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445. PubMedPubMedCentral
45.
Giannouchos, T. V., Biskupiak, J., Moss, M. J., Brixner, D., Andreyeva, E., & Ukert, B. (2021). Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system. American Journal of Emergency Medicine, 40, 20–6.
46.
Chew, B. H. (2015). Medication adherence on quality of life among adults with type 2 diabetes mellitus: An exploratory analysis on the EDDMQoL study. Quality of Life Research, 24(11), 2723–2731. PubMed
47.
Khayyat, S. M., Mohamed, M. M., Khayyat, S. M., Alhazmi, R. S., Korani, M. F., Allugmani, E. B., Saleh, S. F., Mansouri, D. A., Lamfon, Q. A., Beshiri, O. M., & Hadi, M. A. (2019). Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: A cross-sectional survey. Quality of Life Research, 28(4), 1053–61. PubMed
48.
Bulloch, A. G., Adair, C. E., & Patten, S. B. (2006). Forgetfulness: A role in noncompliance with antidepressant treatment. Canadian Journal of Psychiatry, 51(11), 719–722. PubMed
49.
Park, H. Y., Seo, S. A., Yoo, H., & Lee, K. (2018). Medication adherence and beliefs about medication in elderly patients living alone with chronic diseases. Patient Preference and Adherence, 12, 175. PubMedPubMedCentral
50.
Weidenbacher, H. J., Beadles, C. A., Maciejewski, M. L., Reeve, B. B., & Voils, C. I. (2015). Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: The association with depressive symptom burden in a sample of American veterans. Patient Preference and Adherence, 9, 327. PubMedPubMedCentral
51.
Karakurt, P., & Kaşikçi, M. (2012). Factors affecting medication adherence in patients with hypertension. Journal of Vascular Nursing, 30(4), 118–126. PubMed
52.
53.
Pages-Puigdemont, N., Mangues, M. A., Masip, M., Gabriele, G., Fernández-Maldonado, L., Blancafort, S., & Tuneu, L. (2016). Patients’ perspective of medication adherence in chronic conditions: A qualitative study. Advances in Therapy, 33(10), 1740–54. PubMedPubMedCentral
54.
Montori, V. M., Brito, J. P., & Murad, M. H. (2013). The optimal practice of evidence-based medicine: Incorporating patient preferences in practice guidelines. JAMA, 310(23), 2503–2504. PubMed
55.
Aschmann, H. E., Boyd, C. M., Robbins, C. W., Chan, W. V., Mularski, R. A., Bennett, W. L., Sheehan, O. C., Wilson, R. F., Bayliss, E. A., Leff, B., & Armacost, K. (2020). Informing patient-centered care through stakeholder engagement and highly stratified quantitative benefit-harm assessments. Value in Health, 23(5), 616–624. PubMed
56.
Witticke, D., Seidling, H. M., Klimm, H. D., & Haefeli, W. E. (2012). Do we prescribe what patients prefer? Pilot study to assess patient preferences for medication regimen characteristics. Patient Preference and Adherence, 6, 679. PubMedPubMedCentral
57.
Choi, A., Lovett, A. W., Kang, J., Lee, K., & Choi, L. (2015). Mobile applications to improve medication adherence: Existing apps, quality of life and future directions. Advances in Pharmacology and Pharmacy, 3(3), 64–74.
58.
Patel, S., Jacobus-Kantor, L., Marshall, L., Ritchie, C., Kaplinski, M., Khurana, P. S., & Katz, R. J. (2013). Mobilizing your medications: An automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population. Journal of Diabetes Science and Technology, 7(3), 630–639. PubMedPubMedCentral
59.
Grimm, R. H., Grandits, G. A., Cutler, J. A., Stewart, A. L., McDonald, R. H., Svendsen, K., Prineas, R. J., & Liebson, P. R. (1997). Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study. Archives of Internal Medicine, 157(6), 638–648. PubMed
60.
Katsi, V., Kallistratos, M. S., Kontoangelos, K., Sakkas, P., Souliotis, K., Tsioufis, C., Nihoyannopoulos, P., Papadimitriou, G. N., & Tousoulis, D. (2017). Arterial hypertension and health-related quality of life. Frontiers in Psychiatry, 8, 270. PubMedPubMedCentral
61.
Park, N. H., Song, M. S., Shin, S. Y., Jeong, J. H., & Lee, H. Y. (2018). The effects of medication adherence and health literacy on health-related quality of life in older people with hypertension. International Journal of Older People Nursing, 13(3), e12196. PubMed
62.
Papadopoulos, A. A., Kontodimopoulos, N., Frydas, A., Ikonomakis, E., & Niakas, D. (2007). Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health, 7(1), 186. PubMedPubMedCentral
Metagegevens
Titel
Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic
Auteurs
Kyriakos Souliotis
Theodoros V. Giannouchos
Chistina Golna
Evangelos Liberopoulos
Publicatiedatum
22-06-2021
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 1/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02917-y

Andere artikelen Uitgave 1/2022

Quality of Life Research 1/2022 Naar de uitgave

OriginalPaper

Development of a physical function outcome measure to harmonize comparisons between three Asian adult populations

OriginalPaper

Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysis

Review

The influence of psychosocial factors on patient-reported outcome measures in rotator cuff tears pre- and post-surgery: a systematic review

OriginalPaper

Patients’ and parents’ perspective on the implementation of Patient Reported Outcome Measures in pediatric clinical practice using the KLIK PROM portal

Review

Evidence on the relationship between PROMIS-29 and EQ-5D: a literature review

OriginalPaper

Sexual orientation and quality of life of people living with HIV/AIDS in China: evidence from an institutional-based cross-sectional study